The clinical immunobiology of interleukin-2: potential modified uses for improved cancer treatment

about

The clinical immunobiology of interleukin-2: potential modified uses for improved cancer treatment

Item

http://www.wikidata.org/entity/Q35657649

description

1989 nî lūn-bûn

@nan

1989年の論文

@ja

1989年論文

@yue

1989年論文

@zh-hant

1989年論文

@zh-hk

1989年論文

@zh-mo

1989年論文

@zh-tw

1989年论文

@wuu

1989年论文

@zh

1989年论文

@zh-cn

name

The clinical immunobiology of ...... for improved cancer treatment

@ast

The clinical immunobiology of ...... for improved cancer treatment

@en

type

Item

label

The clinical immunobiology of ...... for improved cancer treatment

@ast

The clinical immunobiology of ...... for improved cancer treatment

@en

prefLabel

The clinical immunobiology of ...... for improved cancer treatment

@ast

The clinical immunobiology of ...... for improved cancer treatment

@en

P1476

The clinical immunobiology of ...... for improved cancer treatment

@en

P2093

G Weil-Hillman

http://www.w3.org/2001/XMLSchema#string

J A Hank

http://www.w3.org/2001/XMLSchema#string

J A Sosman

http://www.w3.org/2001/XMLSchema#string

P M Sondel

http://www.w3.org/2001/XMLSchema#string

S D Voss

http://www.w3.org/2001/XMLSchema#string

P2860

New perspectives in cell adhesion: RGD and integrins

Treatment of immunodeficiency with interleukin-2: initial exploration.

The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells.

Selective in vitro growth of T lymphocytes from normal human bone marrows.

Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2.

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.

The human interleukin 2 receptor beta chain (p70). Direct identification, partial purification, and patterns of expression on peripheral blood mononuclear cells.

The human interleukin-2 receptor: a molecular and biochemical analysis of structure and function.

Immunotherapy of cancer using interleukin 2: current status and future prospects.

Interleukin-2: inception, impact, and implications.

P304

93-110

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1989-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

2690996

http://www.w3.org/2001/XMLSchema#string

P932

1807781

http://www.w3.org/2001/XMLSchema#string